Clinical Trials Logo

Clinical Trial Summary

Anaplasmosis is a tick-borne transmitted infection. Its clinical expression include fever, cytopenia and hepatitis.This infection was initially described in United States. In Europe, its epidemiology is not well known. Some isolated cases have been diagnosed in several country, were the tick Ixodes ricinus is known to transmitted another infection :the Lyme borreliosis.The purpose of our study is to look systematically for Anaplasmosis, in patient living in Eastern France, and presenting with compatible clinical symptoms using a new diagnosis tool : PCR in blood samples. So we will have new data about epidemiology in our country and the clinical symptoms that are associated with Anaplasmosis.


Clinical Trial Description

n/a


Study Design

Observational Model: Case-Only, Time Perspective: Prospective


Related Conditions & MeSH terms


NCT number NCT01013636
Study type Observational
Source University Hospital, Strasbourg, France
Contact Yves HANSMANN, MD
Phone 33.3.69.55.05.45
Email yves.hansmann@chru-strasbourg.fr
Status Recruiting
Phase N/A
Start date November 2009

See also
  Status Clinical Trial Phase
Terminated NCT01031537 - Vaccine Study for Tick-Borne Encephalitis Virus (TBEV) Phase 2
Withdrawn NCT04318925 - Evaluation and Follow-up of People With Tick-borne Diseases